Skip to main content

Advertisement

Log in

Cathelicidin LL-37: A Multitask Antimicrobial Peptide

  • Review
  • Published:
Archivum Immunologiae et Therapiae Experimentalis Aims and scope

Abstract

The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of bacterial wall molecules such as lipopolysaccharide and can therefore protect against lethal endotoxemia. Additional reported activities of LL-37 include chemoattractant function, inhibition of neutrophil apoptosis, and stimulation of angiogenesis, tissue regeneration, and cytokine release (e.g. IL-8). Cellular production of LL-37 is affected by multiple factors, including bacterial products, host cytokines, availability of oxygen, and sun exposure through the activation of CAP-18 gene expression by vitamin D3. At infection sites, the function of LL-37 can be inhibited by charge-driven interactions with DNA and F-actin released from dead neutrophils and other cells lysed as the result of inflammation. A better understanding of LL-37’s biological properties is necessary for its possible therapeutic application for immunomodulatory purposes as well as in treating bacterial infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Adams JS, Liu PT, Chun R et al (2007) Vitamin D in defense of the human immune response. Ann N Y Acad Sci 1117:94–105

    Article  PubMed  CAS  Google Scholar 

  • Andersson E, Sorensen OE, Frohm B et al (2002) Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum Reprod 17:2529–2534

    Article  PubMed  CAS  Google Scholar 

  • Bals R, Wang X, Zasloff M et al (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA 95:9541–9546

    Article  PubMed  CAS  Google Scholar 

  • Bals R, Weiner DJ, Meegalla RL et al (1999) Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 103:1113–1117

    Article  PubMed  CAS  Google Scholar 

  • Bandholtz L, Ekman GJ, Vilhelmsson M et al (2006) Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype. Scand J Immunol 63:410–419

    Article  PubMed  CAS  Google Scholar 

  • Barlow PG, Li Y, Wilkinson TS et al (2006) The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 80:509–520

    Article  PubMed  CAS  Google Scholar 

  • Bergman P, Johansson L, Asp V et al (2005) Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol 7:1009–1017

    Article  PubMed  CAS  Google Scholar 

  • Bergman P, Walter-Jallow L, Broliden K et al (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5:410–415

    Article  PubMed  CAS  Google Scholar 

  • Berkestedt I, Nelson A, Bodelsson M (2008) Endogenous antimicrobial peptide LL-37 induces human vasodilatation. Br J Anaesth 100:803–809

    Article  PubMed  CAS  Google Scholar 

  • Brandenburg K, Andra J, Muller M et al (2003) Physicochemical properties of bacterial glycopolymers in relation to bioactivity. Carbohydr Res 338:2477–2489

    Article  PubMed  CAS  Google Scholar 

  • Brandenburg LO, Varoga D, Nicolaeva N et al (2008) Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptide in meningitis. J Neuropathol Exp Neurol 67:1041–1054

    Article  PubMed  CAS  Google Scholar 

  • Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238–250

    Article  PubMed  CAS  Google Scholar 

  • Bucki R, Janmey PA (2006) Interact ion of the Gelsolin-derived antibacterial PBP10 peptides with cell membranes and lipids bilayers. Antimicrob Agents Chemother 50:2932–2940

    Article  PubMed  CAS  Google Scholar 

  • Bucki R, Pastore JJ, Randhawa P et al (2004) Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin. Antimicrob Agents Chemother 48:1526–1533

    Article  PubMed  CAS  Google Scholar 

  • Bucki R, Georges PC, Espinassous Q et al (2005) Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44:9590–9597

    Article  PubMed  CAS  Google Scholar 

  • Bucki R, Byfield FJ, Janmey PA (2007a) Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J 29:624–632

    Article  PubMed  CAS  Google Scholar 

  • Bucki R, Sostarecz AG, Byfield FJ et al (2007b) Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60:535–545

    Article  PubMed  CAS  Google Scholar 

  • Bucki R, Byfield FJ, Kulakowska A et al (2008a) Extracellular gelsolin binds lipoteichoic acid and modulates cellular response to proinflammatory bacterial wall components. J Immunol 181:4936–4944

    PubMed  CAS  Google Scholar 

  • Bucki R, Namiot DB, Namiot Z et al (2008b) Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 62:329–335

    Article  PubMed  CAS  Google Scholar 

  • Carretero M, Escamez MJ, Garcia M et al (2008) In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 128:223–236

    Article  PubMed  CAS  Google Scholar 

  • Chakraborty K, Ghosh S, Koley H et al (2008) Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol 10:2520–2537

    Article  PubMed  CAS  Google Scholar 

  • Chamorro CI, Weber G, Gronberg A et al (2009) The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol 129:937–944

    Article  PubMed  CAS  Google Scholar 

  • Chuang CM, Monie A, Wu A et al (2009) Treatment with LL-37 peptide enhances the antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum Gene Ther 20:303–313

    Article  PubMed  CAS  Google Scholar 

  • Chung WO, Dommisch H, Yin L et al (2007) Expression of defensins in gingiva and their role in periodontal health and disease. Curr Pharm Des 13:3073–3083

    Article  PubMed  CAS  Google Scholar 

  • Cinel I, Opal SM (2009) Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37:291–304

    Article  PubMed  CAS  Google Scholar 

  • Ciornei CD, Sigurdardottir T, Schmidtchen A et al (2005) Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob Agents Chemother 49:2845–2850

    Article  PubMed  CAS  Google Scholar 

  • Cirioni O, Giacometti A, Ghiselli R et al (2006) LL-37 protects rats against lethal sepsis caused by Gram-negative bacteria. Antimicrob Agents Chemother 50:1672–1679

    Article  PubMed  CAS  Google Scholar 

  • Cirioni O, Ghiselli R, Tomasinsig L et al (2008) Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa. Shock 30:443–448

    Article  PubMed  CAS  Google Scholar 

  • Coffelt SB, Scandurro AB (2008) Tumors sound the alarmin(s). Cancer Res 68:6482–6485

    Article  PubMed  CAS  Google Scholar 

  • Coffelt SB, Waterman RS, Florez L et al (2008) Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int J Cancer 122:1030–1039

    Article  PubMed  CAS  Google Scholar 

  • Conner K, Nern K, Rudisill J et al (2002) The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J Am Acad Dermatol 47:347–350

    Article  PubMed  Google Scholar 

  • Cozzolino M, Vidal M, Arcidiacono MV et al (2003) HIV-protease inhibitors impair vitamin D bioactivation to 1, 25-dihydroxyvitamin D. AIDS 17:513–520

    Article  PubMed  CAS  Google Scholar 

  • Davidson DJ, Currie AJ, Reid GS et al (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172:1146–1156

    PubMed  CAS  Google Scholar 

  • De Y, Chen Q, Schmidt AP et al (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192:1069–1074

    Article  Google Scholar 

  • den Hertog AL, van Marle J, Veerman EC et al (2006) The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem 387:1495–1502

    Article  CAS  Google Scholar 

  • Frohm M, Agerberth B, Ahangari G et al (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272:15258–15263

    Article  PubMed  CAS  Google Scholar 

  • Gaudreault E, Gosselin J (2007) Leukotriene B4-mediated release of antimicrobial peptides against cytomegalovirus is BLT1 dependent. Viral Immunol 20:407–420

    Article  PubMed  CAS  Google Scholar 

  • Ginsburg I (2004) Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics? it is enigmatic why this concept is consistently disregarded. Med Hypotheses 62:367–374

    Article  PubMed  CAS  Google Scholar 

  • Hase K, Murakami M, Iimura M et al (2003) Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125:1613–1625

    Article  PubMed  CAS  Google Scholar 

  • Heilborn JD, Nilsson MF, Jimenez CI et al (2005) Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 114:713–719

    Article  PubMed  CAS  Google Scholar 

  • Hosaka Y, Koslowski M, Nuding S et al (2008) Antimicrobial host defense in the upper gastrointestinal tract. Eur J Gastroenterol Hepatol 20:1151–1158

    Article  PubMed  CAS  Google Scholar 

  • Islam D, Bandholtz L, Nilsson J et al (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180–185

    Article  PubMed  CAS  Google Scholar 

  • Johansson J, Gudmundsson GH, Rottenberg ME et al (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718–3724

    Article  PubMed  CAS  Google Scholar 

  • Kandler K, Shaykhiev R, Kleemann P et al (2006) The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol 18:1729–1736

    Article  PubMed  CAS  Google Scholar 

  • Kaus A, Jacobsen F, Sorkin M et al (2008) Host defence peptides in human burns. Burns 34:32–40

    Article  PubMed  Google Scholar 

  • Khine AA, Del Sorbo L, Vaschetto R et al (2006) Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood 107:2936–2942

    Article  PubMed  CAS  Google Scholar 

  • Kim JE, Kim BJ, Jeong MS et al (2005) Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. J Korean Med Sci 20:649–654

    Article  PubMed  CAS  Google Scholar 

  • Koczulla AR, Bals R (2003) Antimicrobial peptides: current status and therapeutic potential. Drugs 63:389–406

    Article  PubMed  CAS  Google Scholar 

  • Koczulla R, von Degenfeld G, Kupatt C et al (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665–1672

    PubMed  CAS  Google Scholar 

  • Kumar A, Yin J, Zhang J et al (2007) Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment. Invest Ophthalmol Vis Sci 48:4664–4670

    Article  PubMed  Google Scholar 

  • Lamb HM, Wiseman LR (1998) Pexiganan acetate. Drugs 56:1047–1052 (discussion 1053–1054)

    Google Scholar 

  • Li X, Li Y, Han H et al (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J Am Chem Soc 128:5776–5785

    Article  PubMed  CAS  Google Scholar 

  • Liu PT, Stenger S, Li H et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773

    Article  PubMed  CAS  Google Scholar 

  • Lopez-Garcia B, Lee PH, Yamasaki K et al (2005) Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 125:108–115

    Article  PubMed  CAS  Google Scholar 

  • Mallbris L, Edstrom DW, Sundblad L et al (2005) UVB upregulates the antimicrobial protein hCAP18 mRNA in human skin. J Invest Dermatol 125:1072–1074

    PubMed  CAS  Google Scholar 

  • Mendez-Samperio P, Miranda E, Trejo A (2008) Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-Guerin. Clin Vaccine Immunol 15:1450–1455

    Article  PubMed  CAS  Google Scholar 

  • Mookherjee N, Brown KL, Bowdish DM et al (2006a) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176:2455–2464

    PubMed  CAS  Google Scholar 

  • Mookherjee N, Wilson HL, Doria S et al (2006b) Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J Leukoc Biol 80:1563–1574

    Article  PubMed  CAS  Google Scholar 

  • Murakami M, Ohtake T, Dorschner RA et al (2002a) Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 81:845–850

    Article  PubMed  CAS  Google Scholar 

  • Murakami M, Ohtake T, Dorschner RA et al (2002b) Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 119:1090–1095

    Article  PubMed  CAS  Google Scholar 

  • Nagaoka I, Hirota S, Niyonsaba F et al (2001) Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 167:3329–3338

    PubMed  CAS  Google Scholar 

  • Nagaoka I, Tamura H, Hirata M (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol 176:3044–3052

    PubMed  CAS  Google Scholar 

  • Nijnik A, Hancock RE (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 16:41–47

    Article  PubMed  CAS  Google Scholar 

  • Niyonsaba F, Ushio H, Nakano N et al (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127:594–604

    Article  PubMed  CAS  Google Scholar 

  • Ooi EH, Wormald PJ, Carney AS et al (2007) Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis patients in a nasal explant model. Am J Rhinol 21:367–372

    Article  PubMed  Google Scholar 

  • Overhage J, Campisano A, Bains M et al (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76:4176–4182

    Article  PubMed  CAS  Google Scholar 

  • Park HJ, Cho DH, Kim HJ et al (2009) Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. J Invest Dermatol 129:843–850

    Article  PubMed  CAS  Google Scholar 

  • Peyssonnaux C, Boutin AT, Zinkernagel AS et al (2008) Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J Invest Dermatol 128:1964–1968

    Article  PubMed  CAS  Google Scholar 

  • Pochet S, Tandel S, Querriere S et al (2006) Modulation by LL-37 of the responses of salivary glands to purinergic agonists. Mol Pharmacol 69:2037–2046

    Article  PubMed  CAS  Google Scholar 

  • Rivas-Santiago B, Hernandez-Pando R, Carranza C et al (2008) Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect Immun 76:935–941

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld Y, Papo N, Shai Y (2006) Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem 281:1636–1643

    CAS  Google Scholar 

  • Schaller-Bals S, Schulze A, Bals R (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165:992–995

    PubMed  Google Scholar 

  • Shaykhiev R, Beisswenger C, Kandler K et al (2005) Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 289:L842–L848

    Article  PubMed  CAS  Google Scholar 

  • Sheils CA, Kas J, Travassos W et al (1996) Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol 148:919–927

    PubMed  CAS  Google Scholar 

  • Skokos D, Nussenzweig MC (2007) CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med 204:1525–1531

    PubMed  CAS  Google Scholar 

  • Smeianov V, Scott K, Reid G (2000) Activity of cecropin P1 and FA-LL-37 against urogenital microflora. Microbes Infect 2:773–777

    Article  PubMed  CAS  Google Scholar 

  • Tai EK, Wong HP, Lam EK et al (2008) Cathelicidin stimulates colonic mucus synthesis by up-regulating MUC1 and MUC2 expression through a mitogen-activated protein kinase pathway. J Cell Biochem 104:251–258

    Article  PubMed  CAS  Google Scholar 

  • Tang JX, Janmey PA (1996) The polyelectrolyte nature of F-actin and the mechanism of actin bundle formation. J Biol Chem 271:8556–8563

    Article  PubMed  CAS  Google Scholar 

  • Tang JX, Wen Q, Bennett A et al (2005) Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am J Physiol Lung Cell Mol Physiol 289:L599–L605

    Article  PubMed  CAS  Google Scholar 

  • Thomas-Virnig CL, Centanni JM, Johnston CE et al (2009) Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue. Mol Ther 17:562–569

    Article  PubMed  CAS  Google Scholar 

  • Tjabringa GS, Ninaber DK, Drijfhout JW et al (2006) Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol 140:103–112

    Article  PubMed  CAS  Google Scholar 

  • Tokumaru S, Sayama K, Shirakata Y et al (2005) Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175:4662–4668

    PubMed  CAS  Google Scholar 

  • Torossian A, Gurschi E, Bals R et al (2007) Effects of the antimicrobial peptide LL-37 and hyperthermic preconditioning in septic rats. Anesthesiology 107:437–441

    Article  PubMed  CAS  Google Scholar 

  • Travis SM, Anderson NN, Forsyth WR et al (2000) Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 68:2748–2755

    Article  PubMed  CAS  Google Scholar 

  • von Haussen J, Koczulla R, Shaykhiev R et al (2008) The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 59:12–23

    Article  Google Scholar 

  • Wah J, Wellek A, Frankenberger M et al (2006) Antimicrobial peptides are present in immune and host defense cells of the human respiratory and gastrointestinal tracts. Cell Tissue Res 324:449–456

    Article  PubMed  CAS  Google Scholar 

  • Walker TS, Tomlin KL, Worthen GS et al (2005) Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73:3693–3701

    Article  PubMed  CAS  Google Scholar 

  • Weiner DJ, Bucki R, Janmey PA (2003) The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am J Respir Cell Mol Biol 28:738–745

    Article  PubMed  CAS  Google Scholar 

  • Woo JS, Jeong JY, Hwang YJ et al (2003) Expression of cathelicidin in human salivary glands. Arch Otolaryngol Head Neck Surg 129:211–214

    PubMed  Google Scholar 

  • Yoshioka M, Fukuishi N, Kubo Y et al (2008) Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol Pharm Bull 31:212–216

    Article  PubMed  CAS  Google Scholar 

  • Yu J, Mookherjee N, Wee K et al (2007) Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol 179:7684–7691

    PubMed  CAS  Google Scholar 

  • Zasloff M (2005) Sunlight, vitamin D, and the innate immune defenses of the human skin. J Invest Dermatol 125:16–17

    Article  Google Scholar 

  • Zasloff M (2006) Fighting infections with vitamin D. Nat Med 12:388–390

    Article  PubMed  CAS  Google Scholar 

  • Zhang Z, Cherryholmes G, Shively JE (2008) Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol 84:780–788

    Article  PubMed  CAS  Google Scholar 

  • Zheng Y, Niyonsaba F, Ushio H et al (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br J Dermatol 157:1124–1131

    Article  PubMed  CAS  Google Scholar 

  • Zuyderduyn S, Ninaber DK, Hiemstra PS et al (2006) The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells. J Allergy Clin Immunol 117:1328–1335

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Drs. Qi Wen and Paul Janmey (University of Pennsylvania) for help with preparing AFM images and discussions and Dr. Paul Savage (Department of Chemistry and Biochemistry, Brigham Young University) for providing us with ceragenin CSA-13.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Bucki.

About this article

Cite this article

Bucki, R., Leszczyńska, K., Namiot, A. et al. Cathelicidin LL-37: A Multitask Antimicrobial Peptide. Arch. Immunol. Ther. Exp. 58, 15–25 (2010). https://doi.org/10.1007/s00005-009-0057-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00005-009-0057-2

Keywords

Navigation